Is Alto Neuroscience financially healthy?
Not really
Alto Neuroscience carries heavy debt: it would take 3.5 years of earnings to pay it off.
The numbers behind it
Net debt / EBITDA3.5 years
Cash vs. debt$176M vs. $24M
Current ratio20.5×Short-term assets for each $1 of bills due within a year
Interest coverage22.7×How many times operating profit covers the interest bill
How we decide
We measure debt in years of earnings (net debt / EBITDA): under 1 is very comfortable, 1 to 3 is manageable, above 3 is heavy. A company that earns less than 3 times its interest bill also counts as weak.
More questions about Alto Neuroscience
Data as of Nov 13, 2026.